| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome
|
Braschel, Melissa C
|
|
2016
|
13 |
2 |
p. 180-187
|
artikel
|
| 2 |
Alignment of site versus adjudication committee–based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial
|
Sepehrvand, Nariman
|
|
2016
|
13 |
2 |
p. 140-148
|
artikel
|
| 3 |
Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management system
|
Zhao, Wenle
|
|
2016
|
13 |
2 |
p. 223-233
|
artikel
|
| 4 |
Avoiding bias and incorrect confidence interval coverage in prescription drug labeling
|
Levin, Gregory
|
|
2016
|
13 |
2 |
p. 199-204
|
artikel
|
| 5 |
Benefits and barriers to participating in longitudinal research of youth-onset type 2 diabetes: Results from the TODAY retention survey
|
Walders-Abramson, Natalie
|
|
2016
|
13 |
2 |
p. 240-243
|
artikel
|
| 6 |
Commentary on Sertkaya et al. and Larson et al.
|
Eisenstein, Eric L
|
|
2016
|
13 |
2 |
p. 137-139
|
artikel
|
| 7 |
Fallacies of last observation carried forward analyses
|
Lachin, John M
|
|
2016
|
13 |
2 |
p. 161-168
|
artikel
|
| 8 |
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP
|
Lazar, Ann A
|
|
2016
|
13 |
2 |
p. 169-179
|
artikel
|
| 9 |
Key cost drivers of pharmaceutical clinical trials in the United States
|
Sertkaya, Aylin
|
|
2016
|
13 |
2 |
p. 117-126
|
artikel
|
| 10 |
Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials
|
Larson, Gregg S
|
|
2016
|
13 |
2 |
p. 127-136
|
artikel
|
| 11 |
Recruiting and retaining young adults in a weight gain prevention trial: Lessons learned from the CHOICES study
|
Moe, Stacey G
|
|
2016
|
13 |
2 |
p. 205-213
|
artikel
|
| 12 |
Recruiting community health centers into pragmatic research: Findings from STOP CRC
|
Coronado, Gloria D
|
|
2016
|
13 |
2 |
p. 214-222
|
artikel
|
| 13 |
Response to Magnus and Wilfond
|
Kim, Scott YH
|
|
2016
|
13 |
2 |
p. 244-245
|
artikel
|
| 14 |
Risks of phase I research with healthy participants: A systematic review
|
Johnson, Rebecca A
|
|
2016
|
13 |
2 |
p. 149-160
|
artikel
|
| 15 |
Sample size under the additive hazards model
|
McDaniel, Lee S
|
|
2016
|
13 |
2 |
p. 188-198
|
artikel
|
| 16 |
Should consent forms used in clinical trials be translated into the local dialects? A survey among past participants in rural Ghana
|
Baiden, Frank
|
|
2016
|
13 |
2 |
p. 234-239
|
artikel
|
Tijdschrift beschrijving